Application of Cardiac Neurohormonal Imaging to Heart Failure, Transplantation, and Diabetes

Research output: Contribution to journalArticle

Abstract

The neurohormonal system adapts to body demands, but in cardiac disease it can become maladaptive. A key component, the sympathetic nervous system, can be imaged with radiotracers such as iodine-123-meta-iodobenzylguanidine (123I-mIBG), a norepinephrine analogue. Parameters assessed are the heart-to-mediastinal ratio (HMR), tracer washout, and regional single photon emission computed tomography (SPECT) defects. Much focus has been on heart failure that has a large neurohormonal pathophysiologic component. 123I-mIBG imaging has powerful risk stratification ability for this high morbidity/mortality condition. A lower HMR increases the likelihood of clinical worsening, ventricular arrhythmias, and cardiac death. 123I-mIBG imaging could potentially guide the use of biventricular pacemakers and ventricular assist devices. Much focus has been on better identifying patients likely to benefit from an implantable cardiac defibrillator. For patients with heart transplant, imaging with 123I-mIBG or the positron emission tomographic (PET) tracer, 11C-hydroxyephedrine (HED), can monitor recovery. In diabetes mellitus, imaging can recognize risk from cardiac autonomic dysfunction prior to clinical manifestations.

Original languageEnglish (US)
JournalCurrent Cardiovascular Imaging Reports
Volume8
Issue number4
DOIs
StatePublished - 2015

Fingerprint

Heart Transplantation
Heart Failure
3-Iodobenzylguanidine
Heart-Assist Devices
Implantable Defibrillators
Sympathetic Nervous System
Single-Photon Emission-Computed Tomography
Iodine
Cardiac Arrhythmias
Heart Diseases
Norepinephrine
Diabetes Mellitus
Electrons
Morbidity
Transplants
Mortality

Keywords

  • I-mIBG
  • Autonomic imaging
  • Cardiac transplant
  • Diabetes mellitus
  • Heart failure

ASJC Scopus subject areas

  • Cell Biology
  • Histology
  • Applied Microbiology and Biotechnology

Cite this

@article{10dc4360ae6d4559bc590025066577cf,
title = "Application of Cardiac Neurohormonal Imaging to Heart Failure, Transplantation, and Diabetes",
abstract = "The neurohormonal system adapts to body demands, but in cardiac disease it can become maladaptive. A key component, the sympathetic nervous system, can be imaged with radiotracers such as iodine-123-meta-iodobenzylguanidine (123I-mIBG), a norepinephrine analogue. Parameters assessed are the heart-to-mediastinal ratio (HMR), tracer washout, and regional single photon emission computed tomography (SPECT) defects. Much focus has been on heart failure that has a large neurohormonal pathophysiologic component. 123I-mIBG imaging has powerful risk stratification ability for this high morbidity/mortality condition. A lower HMR increases the likelihood of clinical worsening, ventricular arrhythmias, and cardiac death. 123I-mIBG imaging could potentially guide the use of biventricular pacemakers and ventricular assist devices. Much focus has been on better identifying patients likely to benefit from an implantable cardiac defibrillator. For patients with heart transplant, imaging with 123I-mIBG or the positron emission tomographic (PET) tracer, 11C-hydroxyephedrine (HED), can monitor recovery. In diabetes mellitus, imaging can recognize risk from cardiac autonomic dysfunction prior to clinical manifestations.",
keywords = "I-mIBG, Autonomic imaging, Cardiac transplant, Diabetes mellitus, Heart failure",
author = "Travin, {Mark I.}",
year = "2015",
doi = "10.1007/s12410-015-9323-3",
language = "English (US)",
volume = "8",
journal = "Current Cardiovascular Imaging Reports",
issn = "1941-9066",
publisher = "Current Medicine Group",
number = "4",

}

TY - JOUR

T1 - Application of Cardiac Neurohormonal Imaging to Heart Failure, Transplantation, and Diabetes

AU - Travin, Mark I.

PY - 2015

Y1 - 2015

N2 - The neurohormonal system adapts to body demands, but in cardiac disease it can become maladaptive. A key component, the sympathetic nervous system, can be imaged with radiotracers such as iodine-123-meta-iodobenzylguanidine (123I-mIBG), a norepinephrine analogue. Parameters assessed are the heart-to-mediastinal ratio (HMR), tracer washout, and regional single photon emission computed tomography (SPECT) defects. Much focus has been on heart failure that has a large neurohormonal pathophysiologic component. 123I-mIBG imaging has powerful risk stratification ability for this high morbidity/mortality condition. A lower HMR increases the likelihood of clinical worsening, ventricular arrhythmias, and cardiac death. 123I-mIBG imaging could potentially guide the use of biventricular pacemakers and ventricular assist devices. Much focus has been on better identifying patients likely to benefit from an implantable cardiac defibrillator. For patients with heart transplant, imaging with 123I-mIBG or the positron emission tomographic (PET) tracer, 11C-hydroxyephedrine (HED), can monitor recovery. In diabetes mellitus, imaging can recognize risk from cardiac autonomic dysfunction prior to clinical manifestations.

AB - The neurohormonal system adapts to body demands, but in cardiac disease it can become maladaptive. A key component, the sympathetic nervous system, can be imaged with radiotracers such as iodine-123-meta-iodobenzylguanidine (123I-mIBG), a norepinephrine analogue. Parameters assessed are the heart-to-mediastinal ratio (HMR), tracer washout, and regional single photon emission computed tomography (SPECT) defects. Much focus has been on heart failure that has a large neurohormonal pathophysiologic component. 123I-mIBG imaging has powerful risk stratification ability for this high morbidity/mortality condition. A lower HMR increases the likelihood of clinical worsening, ventricular arrhythmias, and cardiac death. 123I-mIBG imaging could potentially guide the use of biventricular pacemakers and ventricular assist devices. Much focus has been on better identifying patients likely to benefit from an implantable cardiac defibrillator. For patients with heart transplant, imaging with 123I-mIBG or the positron emission tomographic (PET) tracer, 11C-hydroxyephedrine (HED), can monitor recovery. In diabetes mellitus, imaging can recognize risk from cardiac autonomic dysfunction prior to clinical manifestations.

KW - I-mIBG

KW - Autonomic imaging

KW - Cardiac transplant

KW - Diabetes mellitus

KW - Heart failure

UR - http://www.scopus.com/inward/record.url?scp=84923795266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923795266&partnerID=8YFLogxK

U2 - 10.1007/s12410-015-9323-3

DO - 10.1007/s12410-015-9323-3

M3 - Article

AN - SCOPUS:84923795266

VL - 8

JO - Current Cardiovascular Imaging Reports

JF - Current Cardiovascular Imaging Reports

SN - 1941-9066

IS - 4

ER -